BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families ; volume:14 ; number:1 ; day:14 ; month:6 ; year:2013 ; pages:1-5 ; date:12.2013
BMC medical genetics ; 14, Heft 1 (14.6.2013), 1-5, 12.2013
- Urheber
-
Bērziņa, Dace
- Beteiligte Personen und Organisationen
-
Nakazawa-Miklaševiča, Miki
Zestkova, Jekaterina
Aksenoka, Karina
Irmejs, Arvīds
Gardovskis, Andris
Kalniete, Dagnija
Gardovskis, Jānis
Miklaševičs, Edvīns
SpringerLink (Online service)
- DOI
-
10.1186/1471-2350-14-61
- URN
-
urn:nbn:de:1111-2016071516335
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bērziņa, Dace
- Nakazawa-Miklaševiča, Miki
- Zestkova, Jekaterina
- Aksenoka, Karina
- Irmejs, Arvīds
- Gardovskis, Andris
- Kalniete, Dagnija
- Gardovskis, Jānis
- Miklaševičs, Edvīns
- SpringerLink (Online service)
Ähnliche Objekte (12)
Understanding high-risk business
Focal therapy in intermediate- and high-risk prostate cancer
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
African KhoeSan ancestry linked to high-risk prostate cancer
Transport of the high-risk neonate
High-risk pregnancy and risk of breastfeeding failure
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients
Evolution of a High-Risk Cancer Registry: past, present and future
Understanding high-risk business
Focal therapy in intermediate- and high-risk prostate cancer
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
African KhoeSan ancestry linked to high-risk prostate cancer
Transport of the high-risk neonate
High-risk pregnancy and risk of breastfeeding failure
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients
Evolution of a High-Risk Cancer Registry: past, present and future
Understanding high-risk business
Focal therapy in intermediate- and high-risk prostate cancer
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
African KhoeSan ancestry linked to high-risk prostate cancer
Transport of the high-risk neonate
High-risk pregnancy and risk of breastfeeding failure
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients